Evidence map›Paper›PMID 14963150›Full record

ArticleJournal of virology2004

Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature Swine.

James C Wood, Gary Quinn, Kristen M Suling, Beth A Oldmixon, Brian A Van Tine, Robert Cina, Scott Arn, Christine A Huang, Linda Scobie, David E Onions and 4 more

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03695939 phase1 / phase2completednot on this mapstarted 2019, after this paper: background citation

An Open-label Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of realSKIN® (Skin Xenotransplant) for Complete Closure of Severe and Extensive Deep-Partial and Full-Thickness Burn Wounds

TypeinterventionalSponsorXenoTherapeutics, Inc.Ran2019 to 2023Enrolled25ConditionsDeep Full-thickness Burn Injury (Disorder)ArmsrealSKIN (skin xenotransplant), Human Cadaver Allograft
NCT06223269 phase3recruitingnot on this mapstarted 2024, after this paper: background citation

A Phase III Open-Label, Multicenter, Randomized, Controlled Clinical Trial to Evaluate the Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Mixed-Depth, Full-Thickness Burn Wounds as an Alternative to Autografting

TypeinterventionalSponsorXenoTherapeutics, Inc.Ran2024 to 2026Enrolled50ConditionsBurns Degree Third, Burn (Disorder), Burn Degree Second, Thermal BurnArmsSkin Xenotransplant, Autograft(ing)
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 137 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Infection in xenotransplantation: opportunities and challenges.Current opinion in organ transplantation · 2019
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

James C WoodImmerge BioTherapeutics Inc., Cambridge, Massachusetts 02139, USA.
Gary Quinn
Kristen M Suling
Beth A Oldmixon
Brian A Van Tine
Robert Cina
Scott Arn
Christine A Huang
Linda Scobie
David E Onions
David H Sachs
Henk-Jan Schuurman
Jay A Fishman
Clive Patience
Harvard University · USUniversity of Glasgow · GBUniversity of Alabama at Birmingham · US

Funding

XENOGRAFT TOLERANCE THROUGH MIXED CHIMERISMP01AI045897 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Megan Sykes · 2000 to 2026
$71.9M
TRAINING IN TRANSPLANTATION BIOLOGYT32AI007529 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 1998 to 2024
$6.4M
Lower Infectious Risk Donor Pigs for XenotransplantationR44AI048349 · NIAID · BIOTRANSPLANT, INC. · PI PATIENCE, CLIVE · 2001 to 2002
$750k
NIAID NIH HHS 2 R44 AI48349-02NIAID NIH HHS 5T32-AI07529-04NIAID NIH HHS P01 AI045897NIAID NIH HHS P01-AI45897NIAID NIH HHS T32 AI007529
6 · The paper itself

Abstract

The replication of porcine endogenous retrovirus subgroup A (PERV-A) and PERV-B in certain human cell lines indicates that PERV may pose an infectious risk in clinical xenotransplantation. We have previously reported that human-tropic PERVs isolated from infected human cells following cocultivation with miniature swine peripheral blood mononuclear cells (PBMC) are recombinants of PERV-A with PERV-C. Here, we report that these recombinants are exogenous viruses in miniature swine; i.e., they are not present in the germ line DNA. These viruses were invariably present in miniature swine that transmitted PERV to human cells and were also identified in some miniature swine that lacked this ability. These data, together with the demonstration of the absence of both replication-competent PERV-A and recombinant PERV-A/C loci in the genome of miniature swine (L. Scobie, S. Taylor, J. C. Wood, K. M. Suling, G. Quinn, C. Patience, H.-J. Schuurman, and D. E. Onions, J. Virol. 78:2502-2509, 2004), indicate that exogenous PERV is the principal source of human-tropic virus in these animals. Interestingly, strong expression of PERV-C in PBMC correlated with an ability of the PBMC to transmit PERV-A/C recombinants in vitro, indicating that PERV-C may be an important factor affecting the production of human-tropic PERV. In light of these observations, the safety of clinical xenotransplantation from miniature swine will be most enhanced by the utilization of source animals that do not transmit PERV to either human or porcine cells. Such animals were identified within the miniature swine herd and may further enhance the safety of clinical xenotransplantation.

Indexed as

AnimalsCells, CulturedEndogenous RetrovirusesFemaleHumansIn Situ Hybridization, FluorescenceMaleProvirusesRecombination, GeneticRNA, ViralSwine, MiniatureTransplantation, HeterologousVirus ReplicationRNA, Viral

Identifiers

PMID14963150
PMCPMC369241
OpenAlexW2120540733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.